Possible cognition changes in women with polycystic ovary syndrome: a narrative review

키워드

참고문헌 (119)

1. Wolf WM, "Geographical prevalence of polycystic ovary syndrome as determined by region and race", ethnicity, 2018, pp.15, 2589~
2. Ding T, "The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity : a systematic review and meta-analysis", Oncotarget, 8, pp.96351~96358 (2017)
3. Naz MSG, "The prevalence of polycystic ovary syndromein adolescents : a systematic review andmetaanalysis", Int J Reprod Biomed, 17, pp.533~542 (2019)
4. Riestenberg C, "Pregnancy-related economic burden of polycystic ovary syndrome(PCOS)", Fertil Steril, 112, pp.e43~ (2019)
5. Azziz R, "Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span", J Clin Endocrinol Metab, 90, pp.4650~4658 (2005)
6. Sulaiman MA, "Psychological burden among women with polycystic ovarian syndrome in Oman : a case-control study", Int J Womens Health, 9, pp.897~904 (2017)
7. Saei Ghare Naz M, "Quality of life and emotional states of depression, anxiety and stress in adolescents with polycystic ovary syndrome : a cross-sectional study", Psychol Res Behav Manag, 13, pp.203~209 (2020)
8. Franik G, "The impact of sex hormones and metabolic markers on depressive symptoms and cognitive functioning in PCOS patients", Gynecol Endocrinol, 35, pp.965~969 (2019)
9. "Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome" (2017)[URL]
10. Barnard L, "Cognitive functioning in polycystic ovary syndrome", Psychoneuroendocrinology, 32, pp.906~914 (2007)
11. Fisher GG, "Work Across the Lifespan", pp.17~45 (2019), Elsevier Academic Press
12. Vos SJB, "Modifiable risk factors for prevention of dementia in midlife, late life and the oldest-old : validation of the LIBRA index", J Alzheimers Dis, 58, pp.537~547 (2017)
13. Livingston G, "Dementia prevention, intervention, and care", Lancet, 390, pp.2673~2734 (2017)
14. "Dementia" (2022)[URL]
15. "World Alzheimer report 2018" (2018)[URL]
16. Nichols E, "Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016", Lancet Neurol, 18, pp.88~106 (2019)
17. Guoqing Z, "Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome", Gynecol Endocrinol, 32, pp.655~658 (2016)
18. Harvey RJ, "The prevalence and causes of dementia in people under the age of 65 years", J Neurol Neurosurg Psychiatry, 74, pp.1206~1209 (2003)
19. Hughes TF, "Modifiable midlife risk factors for late-life cognitive impairment and dementia", Curr Psychiatry Rev, 5, pp.73~92 (2009)
20. Bove RM, "Metabolic and endocrine correlates of cognitive function in healthy young women", Obesity(Silver Spring), 21, pp.1343~1349 (2013)
21. Birdsall MA, "Polycystic ovaries in pre and post-menopausal women", Clin Endocrinol(Oxf), 44, pp.269~276 (1996)
22. Elting MW, "Women with polycystic ovary syndrome gain regular menstrual cycles when ageing", Hum Reprod, 15, pp.24~28 (2000)
23. Brown ZA, "The phenotype of polycystic ovary syndrome ameliorates with aging", Fertil Steril, 96, pp.1259~1265 (2011)
24. Noble H, "Reviewing the literature : choosing a review design", Evid Based Nurs, 21, pp.39~41 (2018)
25. Collins JA, "Balancing the strengths of systematic and narrative reviews", Hum Reprod Update, 11, pp.103~104 (2005)
26. Chaney MA, "So you want to write a narrative review article?", J Cardiothorac Vasc Anesth, 35, pp.3045~3049 (2021)
27. Baethge C, "SANRAa scale for the quality assessment of narrative review articles", Res Integr Peer Rev, 4, pp.5~ (2019)
28. Dumitrescu R, "The polycystic ovary syndrome : an update on metabolic and hormonal mechanisms", J Med Life, 8, pp.142~145 (2015)
29. Walters KA, "New perspectives on the pathogenesis of PCOS : neuroendocrine origins", Trends Endocrinol Metab, 29, pp.841~852 (2018)
30. Upadhayay N, "Comparison of cognitive functions between male and female medical students : a pilot study", J Clin Diagn Res, 8, pp.BC12~5 (2014)
31. Ciocca G, "Is testosterone a food for the brain?", Sex Med Rev, 4, pp.15~25 (2016)
32. Pintzka CW, "Changes in spatial cognition and brain activity after a single dose of testosterone in healthy women", Behav Brain Res, 298, pp.78~90 (2016)
33. Rees DA, "White matter microstructure and cognitive function in young women with polycystic ovary syndrome", J Clin Endocrinol Metab, 101, pp.314~323 (2016)
34. McEwen BS, "Estrogen actions in the central nervous system", Endocr Rev, 20, pp.279~307 (1999)
35. Leeners B, "Lack of associations between female hormone levels and visuospatial working memory, divided attention and cognitive bias across two consecutive menstrual cycles", Front Behav Neurosci, 11, pp.120~ (2017)
36. Sundström Poromaa I, "Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective", Front Neurosci, 8, pp.380~ (2014)
37. Pessoa L, "Emotion and cognition and the amygdala : from"what is it?"to"what’s to be done?"", Neuropsychologia, 48, pp.3416~3429 (2010)
38. Barry JA, "Visual-spatial cognition in women with polycystic ovarian syndrome : the role of androgens", Hum Reprod, 28, pp.2832~2837 (2013)
39. Lei Y, "Effects of androgens on the amyloid-β protein in Alzheimer’s disease", Endocrinology, 159, pp.3885~3894 (2018)
40. Chen GF, "Amyloid beta : structure, biology and structurebased therapeutic development", Acta Pharmacol Sin, 38, pp.1205~1235 (2017)
41. Schattmann L, "Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women", Horm Behav, 51, pp.587~596 (2007)
42. Kara O, "The effect of hyperandrogenism and obesity on mindfulness and metacognition in adolescents with polycystic ovary syndrome", Arch Womens Ment Health, 25, pp.911~921 (2022)
43. Lai W, "Plasma luteinizing hormone level affects the brain activity of patients with polycystic ovary syndrome", Psychoneuroendocrinology, 112, pp.104535~ (2020)
44. Rao CV, "Involvement of luteinizing hormone in Alzheimer disease development in elderly women", Reprod Sci, 24, pp.355~368 (2017)
45. Ali SA, "Hormonal influences on cognitive function", Malays J Med Sci, 25, pp.31~41 (2018)
46. Jamil AS, "Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria", Arch Gynecol Obstet, 293, pp.447~456 (2016)
47. Cooney LG, "High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome : a systematic review and meta-analysis", Hum Reprod, 32, pp.1075~1091 (2017)
48. "Androgens and the female brain: the relationship between testosterone levels, depression, anxiety, cognitive function, and emotion processing in females with polycystic ovarian syndrome" (2019)[URL]
49. Mehrabadi S, "Association of depression and anxiety with cognitive function in patients with polycystic ovary syndrome", J Mazandaran Univ Med Sci, 27, pp.159~170 (2017)
50. Llewellyn DJ, "Cognitive function and psychological well-being : findings from a population-based cohort", Age Ageing, 37, pp.685~689 (2008)
51. Marin MF, "Chronic stress, cognitive functioning and mental health", Neurobiol Learn Mem, 96, pp.583~595 (2011)
52. Cooney LG, "Beyond fertility : polycystic ovary syndrome and long-term health", Fertil Steril, 110, pp.794~809 (2018)
53. Kahal H, "The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome : a systematic review and meta-analysis", Sleep Breath, 24, pp.339~350 (2020)
54. Garvey JF, "Epidemiological aspects of obstructive sleep apnea", J Thorac Dis, 7, pp.920~929 (2015)
55. Krysta K, "Cognitive deficits in adults with obstructive sleep apnea compared to children and adolescents", J Neural Transm(Vienna), 124, pp.187~201 (2017)
56. Karapin P, "Cognition in patients with sleep-disordered breathing : can obstructive and central apneic pauses play a different role in cognitive impairment?", Life(Basel), 12, pp.1180~ (2022)
57. Lajoie AC, "Obstructive sleep apnea in neurodegenerative disorders : current evidence in support of benefit from sleep apnea treatment", J Clin Med, 9, pp.297~ (2020)
58. Harrington YA, "Sex hormones, sleep, and memory : interrelationships across the adult female lifespan", Front Aging Neurosci, 14, pp.800278~ (2022)
59. Moura HH, "Polycystic ovary syndrome : a dermatologic approach", An Bras Dermatol, 86, pp.111~119 (2011)
60. Deveci E, "Neurocognition in patients with acne vulgaris", J Psychiatry (2014)[DOI]
61. Mehrabadi S, "The relationship between acne and cognitive function in patients with polycystic ovary syndrome and healthy women", J Guilan Univ of Med Sci, 27, pp.37~42 (2018)
62. Golchai J, "Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals", Indian J Dermatol, 55, pp.352~354 (2010)
63. Yazici K, "Disease-specific quality of life is associated with anxiety and depression in patients with acne", J Eur Acad Dermatol Venereol, 18, pp.435~439 (2004)
64. Perini G, "Cognitive impairment in depression : recent advances and novel treatments", Neuropsychiatr Dis Treat, 15, pp.1249~1258 (2019)
65. Jafferany M, "Understanding psychocutaneous disease : psychosocial & psychoneuroimmunologic perspectives", Int J Dermatol, 59, pp.8~15 (2020)
66. Mashayekhi Goyonlo V, "Cognitive behavioral therapy as an adjuvant therapy in acne excoriée : a randomized controlled clinical trial", J Dermatolog Treat, 33, pp.782~788 (2022)
67. Tavares A, "The prevalence of metabolic syndrome in the different phenotypes of polycystic ovarian syndrome", Rev Bras Ginecol Obstet, 41, pp.37~43 (2019)
68. Pillai BP, "The prevalence of metabolic syndrome in polycystic ovary syndrome in a South Indian population and the use of neck circumference in defining metabolic syndrome", Int J Diabetes Dev Ctries, 35, pp.469~475 (2015)
69. Yates KF, "Impact of metabolic syndrome on cognition and brain : a selected review of the literature", Arterioscler Thromb Vasc Biol, 32, pp.2060~2067 (2012)
70. Lujan ME, "Cognitive function in women with polycystic ovary syndrome(PCOS) : impact of reproductive and metabolic factors", Fertil Steril, 104, pp.E129~ (2015)
71. Neergaard JS, "Metabolic syndrome, insulin resistance, and cognitive dysfunction : does your metabolic profile affect your brain?", Diabetes, 66, pp.1957~1963 (2017)
72. van Gemert T, "Cognitive function is impaired in patients with recently diagnosed type 2 diabetes, but not type 1 diabetes", J Diabetes Res, 2018, pp.1470476~ (2018)
73. Castellano CA, "Regional brain glucose hypometabolism in young women with polycystic ovary syndrome : possible link to mild insulin resistance", PLoS One, 10, pp.e0144116~ (2015)
74. Jarrett BY, "Dysglycemia, not altered sex steroid hormones, affects cognitive function in polycystic ovary syndrome", J Endocr Soc, 3, pp.1858~1868 (2019)
75. Zheng F, "HbA1c, diabetes and cognitive decline : the English Longitudinal Study of Ageing", Diabetologia, 61, pp.839~848 (2018)
76. Janssen J, "HbA1c, insulin resistance, and β-cell function in relation to cognitive function in type 2 diabetes : the CAROLINA cognition substudy", Diabetes Care, 42, pp.e1~3 (2019)
77. Huang Y, "Cognitive disorder in women with polycystic ovary syndrome : a remote complication", J Pediatr Adolesc Gynecol, 27, pp.240~241 (2014)
78. Lim SS, "Overweight, obesity and central obesity in women with polycystic ovary syndrome : a systematic review and meta-analysis", Hum Reprod Update, 18, pp.618~637 (2012)
79. Cook RL, "Relationship between obesity and cognitive function in young women : the food, mood and mind study", J Obes, 2017, pp.5923862~ (2017)
80. Hou Q, "Associations between obesity and cognitive impairment in the Chinese elderly : an observational study", Clin Interv Aging, 14, pp.367~373 (2019)
81. Nguyen JC, "Obesity and cognitive decline : role of inflammation and vascular changes", Front Neurosci, 8, pp.375~ (2014)
82. Li G, "Changes in resting-state cerebral activity in women with polycystic ovary syndrome : a functional mr imaging study", Front Endocrinol(Lausanne), 11, pp.603279~ (2020)
83. Mehrabadi S, "Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome : a cross-sectional study", Int J Reprod Biomed, 18, pp.1049~1058 (2020)
84. Sukhapure M, "Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome", Arch Womens Ment Health, 25, pp.87~94 (2022)
85. Shi Y, "Hypertension in women with polycystic ovary syndrome : prevalence and associated cardiovascular risk factors", Eur J Obstet Gynecol Reprod Biol, 173, pp.66~70 (2014)
86. Joham AE, "Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity", Am J Hypertens, 28, pp.847~851 (2015)
87. Iadecola C, "Impact of hypertension on cognitive function : a scientific statement from the American Heart Association", Hypertension, 68, pp.e67~94 (2016)
88. Birns J, "Cognitive function and hypertension", J Hum Hypertens, 23, pp.86~96 (2009)
89. Read SL, "Fertility history and cognition in later life", J Gerontol B Psychol Sci Soc Sci, 72, pp.1021~1031 (2017)
90. Saenz JL, "Fertility history and cognitive function in late life : the case of Mexico", J Gerontol B Psychol Sci Soc Sci, 76, pp.e140~52 (2021)
91. Palomba S, "Complications and challenges associated with polycystic ovary syndrome : current perspectives", Int J Womens Health, 7, pp.745~763 (2015)
92. Karim R, "John J, Brinton RD, et al. Effect of reproductive history and exogenous hormone use on cognitive function in mid-and late life", J Am Geriatr Soc, 64, pp.2448~2456 (2016)
93. Prince MJ, "Reproductive period, endogenous estrogen exposure and dementia incidence among women in Latin America and China;a 10", 66 population-based cohort study, 2018, pp.13, e0192889~
94. Peterson A, "A lifecourse perspective on female sex-specific risk factors for later life cognition", Curr Neurol Neurosci Rep, 21, pp.46~ (2021)
95. Xu XL, "Estrogen receptors in polycystic ovary syndrome", Cells, 10, pp.459~ (2021)
96. Schelbaum E, "Association of reproductive history with brain MRI biomarkers of dementia risk in midlife", Neurology, 97, pp.e2328~39 (2021)
97. Leeners B, "Cognitive function in association with high estradiol levels resulting from fertility treatment", Horm Behav, 130, pp.104951~ (2021)
98. Legro RS, "Diagnosis and treatment of polycystic ovary syndrome : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 98, pp.4565~4592 (2013)
99. Warren AM, "A systematic review of the impact of oral contraceptives on cognition", Contraception, 90, pp.111~116 (2014)
100. Botsali A, "The effects of isotretinoin on affective and cognitive functions are disparate in adolescent acne vulgaris patients", J Dermatolog Treat, 31, pp.734~738 (2020)
101. Soleman RS, "Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory", Fertil Steril, 105, pp.1314~1321 (2016)
102. Schattmann L, "Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome : a randomized, placebo-controlled treatment study", Horm Behav, 51, pp.579~586 (2007)
103. Alzaid A, "Metformin therapy improves cognitive function in women with polycystic ovary syndrome(PCOS)", Diabetologia, 60(Suppl 1), pp.581~582 (2017)
104. Liu J, "Measuring the global disease burden of polycystic ovary syndrome in 194 countries : Global Burden of Disease Study 2017", Hum Reprod, 36, pp.1108~1119 (2021)
105. 박찬홍, "Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome", Obstetrics & Gynecology Science, 63(1), pp.80~86 (2020), 대한산부인과학회[DOI]
106. Niknaz Moradi, "Ovarian cysts disappear after 14-day oral regimen of Korean red ginseng extract in letrozole-induced polycystic ovarian syndrome", Obstetrics & Gynecology Science, 64(3), pp.274~283 (2021), 대한산부인과학회[DOI]
107. Pasquali R, "Contemporary approaches to the management of polycystic ovary syndrome", Ther Adv Endocrinol Metab, 9, pp.123~134 (2018)
108. Sanchez-Garrido MA, "Metabolic dysfunction in polycystic ovary syndrome : pathogenic role of androgen excess and potential therapeutic strategies", Mol Metab, 35, pp.100937~ (2020)
109. Van Duinkerken E, "The cognitive and psychological effects of living with type 1 diabetes : a narrative review", Diabet Med, 37, pp.555~563 (2020)
110. Sutin AR, "Psychological distress, self-beliefs, and risk of cognitive impairment and dementia", J Alzheimers Dis, 65, pp.1041~1050 (2018)
111. Guicciardi M, "Effects of metabolic syndrome on cognitive performance of adults during exercise", Front Psychol, 10, pp.1845~ (2019)
112. 김범수, "Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome", Experimental and Molecular Medicine, 47, pp.1~10 (2015), 생화학분자생물학회
113. Ozgen Saydam B, "Polycystic ovary syndrome and brain : an update on structural and functional studies", J Clin Endocrinol Metab, 106, pp.e430~41 (2020)
114. Gaspar JM, "Inside the diabetic brain : role of different players involved in cognitive decline", ACS Chem Neurosci, 7, pp.131~142 (2016)
115. Rocha AL, "Recent advances in the understanding and management of polycystic ovary syndrome", F1000Res (2019)[DOI]
116. Boivin MJ, "Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation", BMC Womens Health, 20, pp.132~ (2020)
117. Teede HJ, "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome", Hum Reprod, 33, pp.1602~1618 (2018)
118. Barry JA, "Psychological aspects of polycystic ovary syndrome" (2019), Palgrave Macmillan
119. Ranjbar F, "Evaluation of spatial memory in women with polycystic ovary syndrome", Iran J Obstet Gynecol Infertil, 23, pp.1~9 (2020)

관련 논문AI추천